%PDF-1.4
%
39 0 obj
<>
endobj
36 0 obj
<>
endobj
108 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-08-05T13:39:31Z
2024-03-28T03:31:18-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T03:31:18-07:00
application/pdf
Heather
2005-289.aug
uuid:e0e95516-1dd1-11b2-0a00-8a0827bd7700
uuid:e0e95519-1dd1-11b2-0a00-900000000000
endstream
endobj
25 0 obj
<>
endobj
26 0 obj
<>
endobj
40 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
134 0 obj
[138 0 R]
endobj
135 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
12 789 587 -785 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 73.368 737.5293 Tm
[(Diversity and plasticity of the anti-DNA)-220.2 (topoisomerase I )]TJ
0 Tc 0 -1.25 TD
[(autoantibody response in scleroderma. )54.8 (Arthritis Rheum)]TJ
0 Tw T*
(2000;43:2733-42.)Tj
0.0249 Tw -2.175 -1.25 Td
[(72.)-875 (Plotz PH. )17.7 (The autoantibody repertoire: searching for order)54.9 (. Nature)]TJ
2.175 -1.25 Td
(Rev Immunol 2003;3:73-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(73.)-875.1 (D\222Arpa P)110.7 (, Machlin PS, Ratrie H 3rd, Rothfield NF)79.7 (, Cleveland DW)91.7 (,)]TJ
2.175 -1.25 Td
[(Earnshaw )17.7 (WC. cDNA)-220.2 (cloning of human DNA)-220.2 (topoisomerase I: )]TJ
0 Tc T*
(catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc)Tj
-0.00011 Tc T*
[(Natl )54.8 (Acad Sci USA)-220.2 (1988;85:2543-7.)]TJ
-2.175 -1.25 Td
[(74.)-875.1 (Kuwana M, Kaburaki J, Mimori )17.7 (T)73.9 (,)-0.1 ( Homma M. )54.8 (Autoantibody)]TJ
2.175 -1.25 Td
[(reactive with three classes of RNA)-220.2 (polymerases in sera from)]TJ
0 Tc T*
(patients with systemic sclerosis. J Clin Invest 1993;91:1399-404.)Tj
-2.175 -1.25 Td
[(75.)-875 (Cox JV)128.9 (, Schenk EA, Olmsted JB. Human anticentromere )]TJ
2.175 -1.25 Td
[(antibodies: distribution, characterization of antigens, and ef)17.8 (fect on)]TJ
T*
[(microtubule or)17.8 (ganization. Cell 1983;35:331-9.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(76.)-875.1 (Bernat RL, Borisy GG, Rothfield NF)79.7 (, Earnshaw )17.7 (WC. Injection of)]TJ
0 Tc 2.175 -1.25 Td
(anticentromere antibodies in interphase disrupts events required for)Tj
T*
[(chromosome movement at mitosis. J Cell Biol 1990;1)36.8 (1)36.9 (1:1519-33.)]TJ
-2.175 -1.25 Td
[(77.)-875 (Chizzolini C, Rashi E, Rizzonico R, et al. )54.9 (Autoantibodies to )]TJ
2.175 -1.25 Td
(fibroblasts induce a proadhesive and proinflammatory phenotype in)Tj
-0.00011 Tc T*
[(patients with systemic sclerosis. )54.8 (Arthritis Rheum 2002;46:1602-13.)]TJ
0 Tc -2.175 -1.25 Td
[(78.)-875 (Ronda N, Gatti R, Giacosa R, Raschi E, )17.7 (T)69.8 (estoni C, Meroni PL.)]TJ
-0.00011 Tc 2.175 -1.25 Td
(Antifibroblast antibodies from systemic sclerosis patients are )Tj
0 Tc T*
[(internalized by fibroblasts via a caveolin-linked pathway)64.9 (. )54.9 (Arthritis)]TJ
T*
(Rheum 2002;46:1595-601.)Tj
-0.00011 Tc 30.825 30 Td
[(79.)-875.1 (DeGior)17.7 (gio LA, Konstantinov K, Lee SC, Hardin JA, )17.7 (V)129 (olpe BT)73.9 (,)]TJ
2.175 -1.25 Td
[(Diamond B. )54.8 (A)-219.9 (subset of lupus anti-DNA)-220.2 (antibodies cross-reacts)]TJ
0 Tc T*
(with the NR2 glutamate receptor in systemic lupus erythematosus.)Tj
T*
[(Nature 2001;7:1)36.9 (189-93.)]TJ
-2.175 -1.25 Td
[(80.)-875 (Howard OM, Dong HF)79.8 (, )36.8 (Y)100.1 (ang D, et al. Histidyl\226tRNA)-220.1 (synthetase)]TJ
2.175 -1.25 Td
[(and asparaginyl\226tRNA)-220.1 (synthetase, autoantigens in myositis, )]TJ
T*
[(activate chemokine receptors on )17.8 (T)-257.2 (lymphocytes and immature )]TJ
T*
(dendritic cells. J Exp Med 2002;196:781-91.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(81.)-875.1 (Zhou X, )17.7 (T)69.7 (an FK, Xiong M, et al. Systemic sclerosis \(scleroderma\):)]TJ
0 Tc 2.175 -1.25 Td
(specific autoantigen genes are selectively overexpressed in )Tj
T*
(scleroderma fibroblasts. J Immunol 2001;167:7126-33.)Tj
-2.175 -1.25 Td
[(82.)-875 (V)111.1 (elthuis PJ, Kater L, van der )17.7 (T)69.8 (weel I, et al. In vivo antinuclear )]TJ
2.175 -1.25 Td
(antibody of the skin: diagnostic significance and association with)Tj
T*
[(selective antinuclear antibodies. )54.9 (Ann Rheum Dis 1990;49:163-7.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(83.)-875.1 (Chen ZY)128.8 (, Dobson RL, )54.8 (Ainsworth SK, Silver RM, Rust PF)79.7 (, Maricq)]TJ
2.175 -1.25 Td
[(HR. Immunofluorescence in skin specimens from three dif)17.7 (ferent)]TJ
0 Tc T*
(biopsy sites in patients with scleroderma. Clin Exp Rheumatol)Tj
0 Tw T*
[(1985;3:1)36.9 (1-6.)]TJ
0.0249 Tw -2.175 -1.25 Td
[(84.)-875 (Bryan C, Knight C, Black CM, Silman )54.8 (AJ. Prediction of five-year)]TJ
2.175 -1.25 Td
(survival following presentation with scleroderma: development of a)Tj
-0.00011 Tc T*
[(simple model using three disease factors at first visit. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 1999;42:2660-5.)Tj
ET
/CS0 CS 0 0 0 1 SCN
52.97 77 m
557.97 77 l
S
0 0 0 0 scn
493.79 69.86 64.18 -15.66 re
f*
BT
0 0 0 1 scn
/TT1 1 Tf
0 Tw 8 0 0 8 540.968 56.9344 Tm
(1649)Tj
ET
0 0 0 0 scn
53.03 71.01 203 -16.46 re
f*
BT
0 0 0 1 scn
/TT1 1 Tf
0.02499 Tw 8 0 0 8 54.032 57.2836 Tm
(Editorial: Sen\351cal, et al)Tj
ET
0 0 0 0 scn
/GS0 gs
104.13 82.48 407.5 -10.83 re
f*
0.5 w
104.13 82.48 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
93 0 obj
<>
endobj
113 0 obj
<>
endobj
45 0 obj
<>
endobj
42 0 obj
<>
endobj
46 0 obj
<>
endobj
71 0 obj
<>stream
HV lޛ]1v9
ʂLe dPr PHI))%1
*
HQQA((oJ}y ڡ
ƾ˿71%;i bUIM~zXU3*_>p bxuay%g DEYtǕc͌w>D|@UTV/
G 6,̓oe{t0W5{^uzeU_0Ʉ(ukDZ!:*H,bnP/%hDž:X\FtG:Y"\&,m$`8fc*pvb=(/E
ӐKۿr0 р8ؙB)G6*&X;`Fo!Y͘QI\o:żh8S]G,ш!(NGD\zuDx0##EXDv gTY[y^WO#c1a=>F2fmCwА;3qW8qWD(LliUreu y٤u?$ɘ w^POp[$n[d|NNUԕeZd'd_"Q|h-~ޭ#؇4.M8E.EJ2Nrd(CI
`"k)?Ͻ:MT".e5K9V}lÇS814>Eͪ
aW8Q#ZT)8J>9E.+g<-W
(.:\-Vwj4mVrd?z945T:f9h+ݪ[Fvp%#0ؑvupMt؛zs3;٧Ox09\af? $ Tֹ3sŌ3 Pd1ULBEq%"vq@\mWQe&;3\rx*"\-ߕr4yVJ*1J@Q*۔?Jr_y:ղA8jc҇#ywfFsݟMKfʥw풒9!>.Sg:ĴnնMdӡ~Lj1b '~S(iS-=,R0ȝ{